High Febrile Neutropenia Risk With Docetaxel in Prostate Cancer ...Middle East

Medscape - News
The risk is high enough to consider routine febrile neutropenia prophylaxis in patients with metastatic castration-resistant disease. The study was published as a preprint and has not been peer reviewed. First Look

Hence then, the article about high febrile neutropenia risk with docetaxel in prostate cancer was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( High Febrile Neutropenia Risk With Docetaxel in Prostate Cancer )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News
Parade - before 9 hours & 20 minute